Quick Answer
Cullinan Therapeutics, Inc. reported Shares Outstanding of 60.24 million shares for fiscal year 2025.
Cullinan Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 60.24M | +3.0% |
| 2024 | 58.51M | +36.4% |
| 2023 | 42.90M | -6.3% |
| 2022 | 45.80M | +3.4% |
| 2021 | 44.29M | +48.5% |
| 2020 | 29.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 59.08M | +1.6% | +0.0% |
| June 30, 2025 | 59.07M | +2.1% | +0.6% |
| March 31, 2025 | 58.70M | +36.3% | +0.3% |
| December 31, 2024 | 58.51M | +36.4% | +0.6% |
| September 30, 2024 | 58.14M | +36.0% | +0.5% |
| June 30, 2024 | 57.87M | +35.4% | +34.4% |
| March 31, 2024 | 43.07M | +9.5% | +0.4% |
| December 31, 2023 | 42.90M | -6.3% | +0.3% |
- Cullinan Therapeutics, Inc. showed an increase of +3.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Cullinan Therapeutics, Inc.’s shares outstanding has grown by 102.0% (from 29.83 million shares to 60.24 million shares).
- The most recent figure is from Cullinan Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: